NCT00817726View on ClinicalTrials.gov

RBD Longitudinal as Prognostic for PD

Active, not recruitingOBSERVATIONAL
Enrollment

164

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

December 31, 2024

Study Completion Date

May 31, 2025

Conditions
Rapid Eye Movement Sleep Behavior Disorder
Trial Locations (1)

77030

University of texas Health Science Center at Houston, Houston

All Listed Sponsors
lead

The University of Texas Health Science Center, Houston

OTHER

NCT00817726 - RBD Longitudinal as Prognostic for PD | Biotech Hunter | Biotech Hunter